XML 152 R134.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Segments and Geographic Information - Schedule of Business Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Segment Information                      
Net sales $ 6,010 $ 6,294 $ 6,255 $ 6,016 $ 6,002 $ 6,270 $ 6,283 $ 6,055 $ 24,575 $ 24,610 $ 26,161
Selling, general and administrative expenses                 4,221 19,198 7,232
Research, development and related expenses                 1,085 1,154 1,160
Total Company operating income (loss)                 4,822 (10,689) 4,369
Gain on business divestitures [1]                 0 36 2,724
Total operating expenses                 19,753 35,299 21,792
Other expense (income), net                 3 582 165
Income (loss) from continuing operations before income taxes                 4,819 (11,271) 4,204
Assets 39,868       36,858       39,868 36,858  
Depreciation & Amortization                 1,224 1,433 1,254
Capital Expenditures                 1,104 1,388 1,477
Operating Segments                      
Business Segment Information                      
Net sales                 24,272 24,483 25,798
Total Company operating income (loss)                 5,001 4,540 3,086
Operating Segments | Safety and Industrial                      
Business Segment Information                      
Net sales                 10,961 10,956 11,604
Cost of sales                 5,965 6,137 6,510
Selling, general and administrative expenses                 2,020 2,023 3,467
Research, development and related expenses                 485 472 492
Total Company operating income (loss)                 2,491 2,324 1,135
Assets 10,877       11,212       10,877 11,212  
Depreciation & Amortization                 556 530 566
Capital Expenditures                 373 285 512
Operating Segments | Transportation and Electronics                      
Business Segment Information                      
Net sales                 8,380 8,501 8,902
Cost of sales                 5,106 5,524 5,413
Selling, general, administrative and goodwill impairment expenses                 1,236 1,207 2,042
Research, development and related expenses                 460 458 474
Total Company operating income (loss)                 1,578 1,312 973
Assets 6,531       6,826       6,531 6,826  
Depreciation & Amortization                 458 537 410
Capital Expenditures                 468 723 562
Operating Segments | Consumer                      
Business Segment Information                      
Net sales                 4,931 5,026 5,292
Cost of sales                 2,912 3,064 3,252
Selling, general and administrative expenses                 955 933 943
Research, development and related expenses                 132 125 119
Total Company operating income (loss)                 932 904 978
Assets 2,518       2,625       2,518 2,625  
Depreciation & Amortization                 157 160 148
Capital Expenditures                 80 105 146
Corporate and Unallocated                      
Business Segment Information                      
Net sales                 271 90 82
Net costs for significant litigation                 (45) (14,785) (877)
Divestiture costs                 (20) (13) (8)
Gain on business divestitures                 0 36 2,724
Divestiture-related restructuring actions                 0 0 (41)
Russia exit (charges) benefits                 0 18 (101)
Total corporate special items                 (65) (14,744) 1,697
Other corporate (expense) income - net                 (108) (540) (484)
Total operating expenses                 (173) (15,284) 1,213
Assets $ 19,942       $ 16,195       19,942 16,195  
Depreciation & Amortization                 53 206 130
Capital Expenditures                 183 275 257
Other                      
Business Segment Information                      
Net sales                 32 37 281
Total Company operating income (loss)                 $ (6) $ 55 $ 70
[1] The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.